Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group (Q39451910)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group |
scientific article |
Statements
1 reference
Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group (English)
1 reference
N T Mathew
1 reference
M Asgharnejad
1 reference
M Peykamian
1 reference
A Laurenza
1 reference
1 December 1997
1 reference
1 reference
49
1 reference
6
1 reference
1485-1490
1 reference
Identifiers
1 reference
1 reference